<aside>
Renin–Angiotensin–Aldosterone System (RAAS) is a critical hormonal cascade that regulates blood pressure, fluid balance, and electrolyte homeostasis. It plays a central role in the pathophysiology of hypertension, heart failure, and renal diseases like renovascular hypertension and chronic kidney disease (CKD).
</aside>
The Renin Angiotensin Aldosterone System (RAAS)
| Component | Source | Function |
|---|---|---|
| Renin | Juxtaglomerular (JG) cells of kidney | Converts angiotensinogen to angiotensin I |
| Angiotensinogen | Liver | Inactive precursor; substrate for renin |
| Angiotensin I | Blood plasma | Inactive; converted to angiotensin II |
| Angiotensin-Converting Enzyme (ACE) | Lungs & vascular endothelium | Converts angiotensin I → angiotensin II |
| Angiotensin II | Blood plasma | Potent vasoconstrictor, stimulates aldosterone |
| Aldosterone | Adrenal cortex (zona glomerulosa) | Promotes Na⁺ and water reabsorption, K⁺ excretion in kidneys |
| Target | Effect of RAAS Activation |
|---|---|
| Blood vessels | Vasoconstriction → ↑ systemic vascular resistance |
| Kidneys | Na⁺/H₂O retention, K⁺ excretion → ↑ blood volume |
| Adrenal gland | Aldosterone secretion |
| Brain | Stimulates thirst, ↑ ADH secretion |
| Heart | May contribute to remodeling and hypertrophy (chronic activation) |
| Test | Purpose |
|---|---|
| Plasma renin activity (PRA) | Assess renin levels |
| Serum aldosterone | Elevated in primary hyperaldosteronism or RAAS activation |
| Aldosterone-to-renin ratio (ARR) | Key screen for primary aldosteronism |